0001179110-12-013995.txt : 20120913
0001179110-12-013995.hdr.sgml : 20120913
20120913150641
ACCESSION NUMBER: 0001179110-12-013995
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120912
FILED AS OF DATE: 20120913
DATE AS OF CHANGE: 20120913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marucci Anthony S
CENTRAL INDEX KEY: 0001429933
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 121089979
MAIL ADDRESS:
STREET 1: 66 COLD HILL DRIVE
CITY: MENDAHM
STATE: NJ
ZIP: 07945
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: 7814330771
MAIL ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494-2725
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
FORM 4 -
X0306
4
2012-09-12
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001429933
Marucci Anthony S
C/O CELLDEX THERAPEUTICS, INC.
119 FOURTH AVENUE
NEEDHAM
MA
02494
1
1
0
0
President & CEO
Incentive Stock Option
5.69
2012-09-12
4
A
0
280000
0.00
A
2013-09-12
2022-09-12
Common Stock
280000
280000
D
25% vest on September 12, 2013 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
/s/ Avery W. Catlin, attorney in fact for Anthony S. Marucci
2012-09-13